Opsens - First clinical Use of OptoWire III After Health Canada Approval

Quebec City, Nov. 7, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the"Company") (TSX:OPS) (OTCQX:OPSSF) today announced the world's first clinical use of the OptoWire III, following the recent Health Canada approval. OptoWire III is a coronary guidewire integrating a second-generation optical sensor for vascular physiological measurement, such as Fractional Flow Reserve ("FFR"). This pressure guidewire is designed to...This story is related to the following:Medical Guidewires
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news